Back to search

Boston University

A cost-benefit analysis of Alzheimer’s disease treatment options

Abstract

dc:description.abstract

Alzheimer’s disease is a neurodegenerative disorder characterized by symptoms such as memory loss and behavioral change, and it is the sixth leading cause of death in the U.S. This literature-based thesis aims to detail the history of the disease as well as pertinent information, such as basic brain histology, disease pathogenesis, and genetic profiles of victims. The paper will then discuss the available treatment options, from their annual costs and mechanisms of action to an evaluation of their cost-effectiveness. The information in this paper was collected through an online investigation of sources including research studies and medical journals. The treatments discussed in this thesis consist of six drugs: aducanumab, donepezil, rivastigmine, galantamine, memantine, and memantine-donepezil combination. Aducanumab is the only disease-modifying drug to receive FDA approval, but its efficacy is marred in controversy and it lacks cost-effectiveness. The remaining five drugs all have similar cost-effective values, but generic donepezil is an outlier with significantly better results. This paper’s findings indicate that generic donepezil is the most optimal treatment, but that further research should be conducted on aducanumab. Research also suggests that public health advocates must be vigorous in their attempts to make these drugs more affordable to the general population.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yaniz, Miguel
Advisors dc:contributor.advisor
  • Tornheim, Keith
  • Offner, Gwynneth D.

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/47465

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Yaniz, Miguel. A cost-benefit analysis of Alzheimer’s disease treatment options. masters thesis, Boston University, 2023. https://hdl.handle.net/2144/47465